Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 7 | Issue 3 | 2016 | pp. 142–5Open access
Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis
- 1*,
- 2,
- 1
- 1 Department of Dermatology, Silchar Medical College, Silchar, Assam, India.
- 2 Department of Dermatology, Burdwan Medical College, Burdwan, West Bengal, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Mahimanjan Saha
Department of Dermatology, Silchar Medical College, Silchar, Assam, India.
Email: mahimanjan@gmail.com
Copyright: © 2016 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2016
- Received:
- Mar 19, 2016
- Accepted:
- Jun 8, 2016
How to cite
Saha, M., Gorai, S., & Madhab, V. (2016). Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis. Journal of Pharmacology and Pharmacotherapeutics, 7(3), 142–5. https://doi.org/10.4103/0976-500X.189681
Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a type of severe adverse cutaneous drug reaction characterized by fever, skin eruption, hematological abnormalities, and internal organ involvement. Although anticonvulsant drugs are mainly implicated in DRESS, newer anticonvulsants such as oxcarbazepine-induced definite cases of DRESS syndrome are rare and oxcarbazepine-induced DRESS syndrome presenting as exfoliative dermatitis is even rarer. We report a case of a 35-year-old male who developed DRESS syndrome presenting as exfoliative dermatitis after taking oxcarbazepine for 3 weeks.
Keywords
Subject
Article metadata
| Title | Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis |
|---|---|
| Authors | Mahimanjan Saha; Surajit Gorai; Vaswatee Madhab |
| Affiliations | Department of Dermatology, Silchar Medical College, Silchar, Assam, India.; Department of Dermatology, Burdwan Medical College, Burdwan, West Bengal, India. |
| Corresponding author | mahimanjan@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 7, Issue 3 (2016) |
Also in this issue
- The three Rs of written assessment: The JIPMER experiencepp. 115–116
- What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trialspp. 120–121
- Phenytoin‑induced toxic epidermal necrolysis: Review and recommendationspp. 127–132
- Deprescription: The prescription metabolismpp. 133–137
- Cold sodium chloride solution 0.9% and infrared thermography can be an alternative to radiopaque contrast agents in phlebographypp. 138–9
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026